AwardedTender

Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zur Wirkstoffkombination Vilanterol und Umeclidiniumbromid

At a glance

AOK Baden-Württemberg is procuring Pharmaceutical products (CPV 33600000) in Stuttgart, Stadtkreis (DE111). It has been awarded. Procedure type: Negotiated without prior call for competition.

From the notice

Vereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit der Wirkstoffkombination Vilanterol und Umeclidiniumbromid (Anoro®). Ein genauer Auftragswert kann nicht ermittelt werden, da dieser von diversen unbekannten Faktoren abhängt. Der Auftragswert für den vergebenen Auftrag kann deshalb nur als fiktiver Wert angegeben werden basierend auf den aktuell geltenden Schwellenwerten.

Key facts

Each fact is from the official notice, last checked 4 November 2026, 15:10 (UTC+01:00).

Status
AwardedOfficial notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Deadline
No deadline in the noticeOfficial notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Buyer
AOK Baden-Württemberg, Stuttgart, DEOfficial notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Place of performance
Stuttgart, Stadtkreis (DE111)Official notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Procedure
Negotiated without prior call for competitionOfficial notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
Lots
1Official notice · checked 4 Nov 2026, 15:10 (UTC+01:00)
First published
28 October 2026, 07:09 (UTC+00:00)Official notice · checked 4 Nov 2026, 15:10 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zur Wirkstoffkombination Vilanterol und… — AOK Baden-Württemberg. A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zur Wirkstoffkombination Vilanterol und Umeclidiniumbromid

    Vereinbarung gemäß gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit der Wirkstoffkombination Vilanterol und Umeclidiniumbromid (Anoro®)

    CPV
    Pharmaceutical products (CPV 33600000)
    Place
    Stuttgart, Stadtkreis (DE111)

Timeline

  1. 27 October 2026: Award. Winner: GlaxoSmithKline GmbH & Co. KG; Tenders received: 1; Lot LOT-0001.
  2. 28 October 2026, 07:09 (UTC+00:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice

Buyer and place

Buyer

AOK Baden-Württemberg
Stuttgart, DE

Place of performance

  • Stuttgart, Stadtkreis (DE111)

Other parties in the notice

  • GlaxoSmithKline GmbH & Co. KG (Tenderer), München
  • GlaxoSmithKline GmbH & Co. KG (Winner), München

Classification

CPV codes

  • 33600000: Pharmaceutical products

NUTS regions

  • DE111: Stuttgart, Stadtkreis

Official documents

No documents found in the indexed notice.

Questions and answers

Who is the buyer?

AOK Baden-Württemberg, Stuttgart, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Where is the work performed (NUTS)?

Stuttgart, Stadtkreis (DE111).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Negotiated without prior call for competition.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
TED
Last checked
4 November 2026, 15:10 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version